Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06225583 · ClinicalTrials.gov registry record

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

A clinical trial of Lower Back Pain and Bertolotti's Syndrome, sponsored by The Cleveland Clinic.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06225583 is a study of Lower Back Pain and Bertolotti's Syndrome that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 40 participants, above the 18-participant average among 4 other Lower Back Pain trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06225583, a study of Lower Back Pain and Bertolotti's Syndrome, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-17
Est. Completion 2026-12-31

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT06225583

The ClinicalTrials.gov registry entry for NCT06225583 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 18-participant average among 4 other Lower Back Pain trials with a reported enrollment target (122% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lower Back Pain appearing as the primary indexed condition, and to 0 interventions.

NCT06225583 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06225583 about?

NCT06225583 is a clinical study titled "Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers". The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be an...

What is the current status of trial NCT06225583?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-01-17. Estimated completion is 2026-12-31.

What conditions does trial NCT06225583 study?

This clinical trial studies the following conditions: Lower Back Pain, Bertolotti's Syndrome.

Who is sponsoring clinical trial NCT06225583?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06225583 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.